InSite Vision Inc. (OTCMKTS:INSV) Surges In Both Volume And Price

[[tagnumber 0]][[tagnumber 1]]InSite Vision Inc. (OTCMKTS:INSV)’s performance in the past several months has been rather decent. After climbing the charts in June we saw the ticker manage to stabilize its price and continue in a seemingly straight line.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]This month we have seen [[tagnumber 6]]INSV[[tagnumber 7]] rise even higher after the company filed its report for the second quarter of the year. The numbers contained in it were pretty decent for an OTC company and managed to provide for the easy increase in price and volumes that followed the filing of the report.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 11]] [[tagnumber 12]]cash: $1.75 million[[tagnumber 13]] [[tagnumber 12]]current assets: $3.22 million[[tagnumber 13]] [[tagnumber 12]]current liabilities: $17.43 million[[tagnumber 13]] [[tagnumber 12]]revenues: $353 thousand[[tagnumber 13]] [[tagnumber 12]]net loss: $6.63 million[[tagnumber 13]] [[tagnumber 22]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]And although these numbers aren’t as good as those that some other OTC pharmaceutical companies can boast about, INSV has managed to keep investor attention through merger news. The company first announced that it was going to merge with Canadian biotech QLT Inc. (TSE:QLT) back in the beginning of June.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]Since then, however, things have changed and the latest news indicated that [[tagnumber 6]]INSV[[tagnumber 7]] itself might be acquired by an unnamed multi–national pharmaceutical company for $0.25 per share in cash. The news came last Friday and helped push the ticker 11.67% in the “right” direction after 2.26 million shares changed hands and [[tagnumber 6]]INSV[[tagnumber 7]] generated $525 thousand in daily dollar volume as the company stock went for a close at $0.2401.[[tagnumber 2]] [[tagnumber 0]] [[tagnumber 2]] [[tagnumber 0]]The ticker seems fairly stable in today’s trading and we might see another straight line run, but it all depends on the press releases coming from the company in the following days. Just be sure to do your due diligence and weigh out all the risks before putting any money on the line.[[tagnumber 2]]